Roche’s Phase 3 Trial for RG6042 (formerly IONIS HTT-Rx) has been announced: GENERATION-HD1

Roche’s Phase 3 Trial for RG6042 (formerly IONIS HTT-Rx) has been announced: GENERATION-HD1

(Click image to enlarge) 

NOTE: No sites have been announced and enrollment has not started. Stay tuned to HDSA for more info. 

 

Share Tweet

Share a link